Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Live Nasdaq Composite: Market Turmoil Persists With All Eyes On $100 Oil
09:58am, Monday, 09'th Mar 2026
Live Updates Finally! Access 25+ Cryptocurrencies The Easy Way After years of waiting for a good option, SoFi now offers access to major cryptocurrencies like Bitcoin, Ethereum, and Solana, along with
Hims & Hers Catapults After Settling Its Bloody Saga With Novo Nordisk
09:53am, Monday, 09'th Mar 2026
Hims stock rocketed Monday after the telehealth company announced a deal to sell Novo Nordisk's branded weight-loss drugs on its platform.
Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal
09:23am, Monday, 09'th Mar 2026
Telehealth platforms are becoming a gateway for access to blockbuster weight loss medicines. That shift became clearer on Monday after Novo Nordisk dropped its patent infringement lawsuit against digi
Stock Futures Fall as Oil Prices Hit Triple Digits
09:15am, Monday, 09'th Mar 2026
Stocks are selling off to start the week, as investors panic about oil prices rising past $100 per barrel
Stock Market Today: Futures Plunge as Oil Tops $100/Barrel; Treasury Yields Jump on Stagflation Fears; Dollar Strengthens
09:00am, Monday, 09'th Mar 2026
Stock futures tumbled and Treasury yields jumped as the price of oil surpassed $100 a barrel Monday, as investors fretted that the ongoing Iran war could slow the U.S. economy.
Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs
08:52am, Monday, 09'th Mar 2026
"We have decided to drop the current court proceedings," Novo CEO Mike Doustdar told CNBC on Monday, however, reserving the right to bring it back "if needed." It comes after an agreement between Novo
What's Happening With HIMS Stock?
08:35am, Monday, 09'th Mar 2026
HIMS has risen 40% pre-market following reports of a settlement and collaboration with Novo Nordisk to market its branded weight-loss drug on the Hims platform.
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit
08:33am, Monday, 09'th Mar 2026
Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday, ending a legal dispute that erup
5 Things to Know Before the Stock Market Opens
08:30am, Monday, 09'th Mar 2026
Stock futures are sharply lower Monday as investors grow increasingly concerned about the impact of the war in the Middle East on the global economy; Oil prices jumped to their highest level in nearly
Hims & Hers Announces Strategic Shift for US Weight Loss Business
08:30am, Monday, 09'th Mar 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evol
Hims And Hers Surges 40% On Deal To Sell Novo Nordisk Obesity Drugs
04:57pm, Saturday, 07'th Mar 2026
Novo Nordisk reportedly will sell its weight-loss drugs via Hims and Hers after a legal feud. Hims and Hers stock surged late Friday.
Why did HIMS stock rally 40% within hours?
12:12pm, Saturday, 07'th Mar 2026
Hims & Hers (NYSE: HIMS) Health stock experienced a dramatic surge in after-hours trading on Friday, transforming what had been a subdued regular session into one of the most explosive moves of the da
Hims & Hers Surprise Rescue: Stock Explodes 40% on GLP-1 Truce
10:56am, Saturday, 07'th Mar 2026
In a dramatic reversal of fortune, Hims & Hers Health ( NYSE:HIMS ) has been rescued by the very company that nearly sank it.
Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report
09:52pm, Friday, 06'th Mar 2026
Novo Nordisk and Hims and Hers Health have reportedly ended their legal feud and are preparing a new partnership to sell Novo's weight-loss drugs on the telehealth platform, surprising investors and s
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
08:04pm, Friday, 06'th Mar 2026
Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal ba
